It's a significant expansion for the MGA Academy of Performing Arts
The newly renovated 30,000 sq ft campus in Livingston marks a significant expansion for the MGA Academy of Performing Arts.
The new campus, based in the former tax office in Almondvale, Livingston, received a multi-million pound investment and will feature one of Scotland’s largest sprung dance floors, which spans 347 sq ft. Giles Auckland Lewis, chief executive of The MGA Academy, said: “It’s a very exciting time for the academy as we open the doors of our brand new campus. There has been a great buzz with new and returning students as they explore all the exceptional facilities.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
West Lothian couple set to travel Europe to complete husband's bucket listRichard Dinnes, 66, was diagnosed with Alzheimer’s four years ago
Læs mere »
Former West Lothian pub landlady marks 103rd birthday with loving familyElla Benson managed the Torphichen Arms in Mid Calder with husband George and was one half of the Gracie Sisters
Læs mere »
Staff at West Lothian removal company tackle Rob Roy Mighty Hike for charityFive members of staff at Purdie Worldwide removal company took on the 26.2 mile hike.
Læs mere »
Windfarm cash is supporting West Lothian good causes£400,000 has been shared between local charities and community groups
Læs mere »
Army, Jeff Monken reach multi-year contract extensionMonken has a 66-50 record in 10 years at Army, including five wins in nine meetings with Navy.
Læs mere »
Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastomaAn innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma, has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.
Læs mere »